Francis Nelson Shen Buys 439,600 Shares of Vitalhub (TSE:VHI) Stock

Vitalhub Corp. (TSE:VHI) Director Francis Nelson Shen bought 439,600 shares of the business’s stock in a transaction on Tuesday, March 24th. The shares were bought at an average price of C$7.00 per share, for a total transaction of C$3,077,200.00. Following the completion of the acquisition, the director owned 588,300 shares of the company’s stock, valued at approximately C$4,118,100. This represents a 295.63% increase in their ownership of the stock.

Francis Nelson Shen also recently made the following trade(s):

• On Thursday, March 26th, Francis Nelson Shen purchased 50,000 shares of Vitalhub stock. The stock was bought at an average cost of C$6.99 per share, with a total value of C$349,500.00.

Vitalhub Stock Performance

Shares of VHI traded down C$0.05 during trading hours on Friday, hitting C$6.93. 208,775 shares of the company were exchanged, compared to its average volume of 359,939. The company has a market cap of C$438.20 million, a PE ratio of 69.30, a PEG ratio of 1.18 and a beta of 0.65. The firm’s 50 day moving average is C$8.10 and its 200-day moving average is C$9.35. Vitalhub Corp. has a 52 week low of C$6.67 and a 52 week high of C$14.64.

Vitalhub (TSE:VHI) last posted its earnings results on Wednesday, March 18th. The company reported C$0.06 earnings per share for the quarter. The firm had revenue of C$31.39 million during the quarter. Vitalhub had a return on equity of 2.75% and a net margin of 5.61%. As a group, equities analysts forecast that Vitalhub Corp. will post 0.2296467 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

VHI has been the topic of a number of recent analyst reports. Raymond James Financial dropped their price target on shares of Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating on the stock in a research report on Tuesday. Royal Bank Of Canada lowered their target price on shares of Vitalhub from C$13.00 to C$12.00 and set an “outperform” rating on the stock in a research note on Monday, January 26th. ATB Cormark Capital Markets dropped their target price on shares of Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating on the stock in a report on Tuesday, March 10th. Finally, Scotiabank cut their target price on shares of Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating for the company in a research report on Wednesday, February 4th. One equities research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the company’s stock. According to data from MarketBeat.com, Vitalhub presently has a consensus rating of “Buy” and a consensus price target of C$13.86.

About Vitalhub

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.